A Speedinvest portfolio company

Molecule

Sector
Health & Bio
Year Invested
2022
Connecting life science research to funding.

Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients - connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.

Switzerland
Share
Links
LinkedIn
Related Companies
aerska

Pioneering RNA medicines to treat, delay, and prevent diseases of the brain.

Sector
Health & Bio
Year Invested
2025
BlubBlub

Video modeling and gamified activities to help children improve their speech and language skills.

Sector
Marketplaces & Consumer
Health & Bio
Year Invested
2017
Charles.co

A digital clinic specializing in men’s health.

Sector
Health & Bio
Year Invested
2022
Doccla

Building the next-gen virtual ward company.

Sector
Health & Bio
Growth
Year Invested
2021
Fertifa

Enabling companies, large and small, to put DEI and employee well-being into practice.

Sector
Health & Bio
Year Invested
2022
Five Lives

Building digital tools for the tracking and improvement of cognitive health.

Sector
Health & Bio
Year Invested
2022
Flinn

Enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficiently.

Sector
Health & Bio
Year Invested
2022
Fuse

Bringing price transparency to US healthcare.

Sector
Health & Bio
Year Invested
2025